The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Correction (v157,p1192)
* Correction (v157,p1038)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Donovan, S. J.
* Articles by Klein, D. F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Donovan, S. J.
* Articles by Klein, D. F.
Related Collections
* Child/Adolescent Psychiatry
* Conduct Disorders
* Other Violence/Aggression
* Anticonvulsants
Am J Psychiatry 157:818-820, May 2000
© 2000 American Psychiatric Association


Brief Report

Divalproex Treatment for Youth With Explosive Temper and Mood Lability: A Double-Blind, Placebo-Controlled Crossover Design

Stephen J. Donovan, M.D., Jonathan W. Stewart, M.D., Edward V. Nunes, M.D., Frederic M. Quitkin, M.D., Michael Parides, Ph.D., William Daniel, C.S.W., Ezra Susser, M.D., Dr.P.H., and Donald F. Klein, M.D.

OBJECTIVE: The authors sought to replicate open-label findings showing that specific criteria for explosive temper and mood lability identify disruptive youth who improve while receiving the anticonvulsant divalproex sodium.METHOD: Twenty outpatient children and adolescents (ages 10–18) with a disruptive behavior disorder (oppositional defiant disorder or conduct disorder) met the specific criteria for explosive temper and mood lability. They received 6 weeks of divalproex treatment and 6 weeks of placebo by random assignment. Independent evaluators blind to group assignment assessed response at the end of each phase.RESULTS: At the end of phase 1, eight of 10 subjects had responded to divalproex; zero of 10 had responded to placebo. Of the 15 subjects who completed both phases, 12 has superior response taking divalproex.CONCLUSIONS: This preliminary study replicates open-label findings showing that divalproex is an efficacious treatment for explosive temper and mood lability in disruptive children and adolescents.




This article has been cited by other articles:


Home page
FocusHome page
E. Leibenluft and B. A. Rich
Pediatric Bipolar Disorder
Focus, July 1, 2008; 6(3): 331 - 347.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
T. R. Kosten and T. A. Kosten
New Medication Strategies for Comorbid Substance Use and Bipolar Affective Disorders
Focus, January 1, 2007; 5(2): 262 - 269.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
J. M. Zito, D. J. Safer, J. F. Gardner, K. Soeken, and J. Ryu
Anticonvulsant Treatment for Psychiatric and Seizure Indications Among Youths
Psychiatr Serv, May 1, 2006; 57(5): 681 - 685.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
S. B. Schur, L. Sikich, R. L. Findling, R. P. Malone, M. L. Crismon, A. Derivan, J. C. MacIntyre II, E. Pappadopulos, L. Greenhill, N. Schooler, et al.
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY), Part I: A Review
Focus, October 1, 2004; 2(4): 596 - 607.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
L. L. Greenhill, S. Pliszka, M. K. Dulcan, W. Bernet, V. Arnold, J. Beitchman, R. S. Benson, O. Bukstein, J. Kinlan, J. McClellan, et al.
Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults
Focus, October 1, 2004; 2(4): 642 - 668.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J. W. Wheless and B. F. D. Bourgeois
Choosing Antiepileptic Drugs for Developmentally Normal Children With Specific Epilepsy Syndromes and Behavioral Disorders
J Child Neurol, August 1, 2004; 19(1_suppl): S39 - S48.
[Abstract] [PDF]


Home page
NeurologyHome page
D. W. Loring and K. J. Meador
Cognitive side effects of antiepileptic drugs in children
Neurology, March 23, 2004; 62(6): 872 - 877.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J. W. Wheless and B. F. D. Bourgeois
Choosing Antiepileptic Drugs for Developmentally Normal Children With Specific Epilepsy Syndromes and Behavioral Disorders
J Child Neurol, January 1, 2004; 19(1_suppl): S39 - S48.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
K. A. Nolan, P. Czobor, B. B. Roy, M. M. Platt, C. B. Shope, L. L. Citrome, and J. Volavka
Characteristics of Assaultive Behavior Among Psychiatric Inpatients
Psychiatr Serv, July 1, 2003; 54(7): 1012 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Journal of Emotional and Behavioral DisordersHome page
D. F. Connor, R. T. Boone, R. J. Steingard, I. D. Lopez, and R. H. Melloni JR
Psychopharmacology and Aggression: II. A Meta-Analysis of Nonstimulant Medication Effects on Overt Aggression-Related Behaviors in Youth with SED
Journal of Emotional and Behavioral Disorders, January 1, 2003; 11(3): 157 - 168.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
R. C. State, L. L. Altshuler, and M. A. Frye
Mania and Attention Deficit Hyperactivity Disorder in a Prepubertal Child: Diagnostic and Treatment Challenges
Am J Psychiatry, June 1, 2002; 159(6): 918 - 925.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
F. G. Moeller, E. S. Barratt, D. M. Dougherty, J. M. Schmitz, and A. C. Swann
Psychiatric Aspects of Impulsivity
Am J Psychiatry, November 1, 2001; 158(11): 1783 - 1793.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. Pakalnis, G. Greenberg, M. E. Drake JR, and J. Paolicchi
Pediatric Migraine Prophylaxis With Divalproex
J Child Neurol, October 1, 2001; 16(10): 731 - 734.
[Abstract] [PDF]


Home page
Trauma Violence AbuseHome page
J. A. COHEN
Pharmacologic Treatment of Traumatized Children
Trauma Violence Abuse, April 1, 2001; 2(2): 155 - 171.
[Abstract] [PDF]


Home page
Evid. Based Ment. HealthHome page
J. D Hamilton
Lithium reduced aggression and was safe in aggressive children and adolescents with conduct disorder admitted to hospital
Evid. Based Ment. Health, February 1, 2001; 4(1): 17 - 17.
[Full Text]


Home page
JWatch PsychiatryHome page
A Medication for Disruptive Behavior Disorders?
Journal Watch Psychiatry, July 5, 2000; 2000(705): 6 - 6.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org